Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Determinants of cancer response to immunotherapy by pd-1 blockade

Determinants of cancer response to immunotherapy by pd-1 blockade

US Patent 12485162 · Granted Dec 2, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biaryl inhibitors of Bruton's tyrosine kinase2023
IRAK4 inhibiting agents2022
Determinants of cancer response to immunotherapy by PD-1 blockade2021
Determinants of cancer response to immunotherapy by PD-1 blockade2021
Biaryl inhibitors of Bruton'S tyrosine kinase2020
Pyrimidinyl tyrosine kinase inhibitors2020
IRAK4 inhibiting agents2020
Biaryl bruton's tyrosine kinase inhibitors2019
IRAK4 inhibiting agents2019
Inhibitors of Bruton's tyrosine kinase2019
Biaryl inhibitors of bruton's tyrosine kinase2018
Heterocyclic compounds useful as PDK1 inhibitors2018